EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES
We have conducted a study of a novel monoclonal A3 antibody raised by means of hybridoma biotechnology. The study was performed with malignant cells of the patients with various lymphoproliferative disorders, and persons with nonmalignant diseases, as compared with intact lymphocytes from healthy pe...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce932ee077a94ad58176c23dd09c4f50 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ce932ee077a94ad58176c23dd09c4f50 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ce932ee077a94ad58176c23dd09c4f502021-11-18T08:03:44ZEXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES1563-06252313-741X10.15789/1563-0625-2014-5-437-442https://doaj.org/article/ce932ee077a94ad58176c23dd09c4f502014-11-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/730https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XWe have conducted a study of a novel monoclonal A3 antibody raised by means of hybridoma biotechnology. The study was performed with malignant cells of the patients with various lymphoproliferative disorders, and persons with nonmalignant diseases, as compared with intact lymphocytes from healthy people,using a method of immunocytochemical staining and indirect immunofluorescence technique. It was found that in cases of lymphoproliferative diseases with low proliferation rates, as based on the numbers of Ki-67 positive cells, as well as in non-malignant blood diseases, the A3 antigen was localized in nucleoli, and it was visualized as focal fluorescence. In malignant lymphoproliferative diseases with high proliferation indexes, the number of brightly fluorescent foci is observed, with formation of necklace-like structures within the nucleolar structures. The obtained data point to a diagnostic significance of A3 Mab in assessment of cellular proliferative rates in patients with various lymphoproliferative diseases. It was established that, in contrast to Ki-67, the proliferation stage could be determined for each cell, according to the number of fuorescent foci in nucleoli. This specific property of the A3 antigen points to its significance for diagnostics and malignancy staging of lymphoproliferative disorders.N. L. DeinekoT. I. BulychevaA. M. KovriginaA. A. GrigoriyvSPb RAACIarticleantigen a3lymphoproliferative diseasesnucleoliimmunocytochemistryImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 16, Iss 5, Pp 437-442 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
RU |
topic |
antigen a3 lymphoproliferative diseases nucleoli immunocytochemistry Immunologic diseases. Allergy RC581-607 |
spellingShingle |
antigen a3 lymphoproliferative diseases nucleoli immunocytochemistry Immunologic diseases. Allergy RC581-607 N. L. Deineko T. I. Bulycheva A. M. Kovrigina A. A. Grigoriyv EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES |
description |
We have conducted a study of a novel monoclonal A3 antibody raised by means of hybridoma biotechnology. The study was performed with malignant cells of the patients with various lymphoproliferative disorders, and persons with nonmalignant diseases, as compared with intact lymphocytes from healthy people,using a method of immunocytochemical staining and indirect immunofluorescence technique. It was found that in cases of lymphoproliferative diseases with low proliferation rates, as based on the numbers of Ki-67 positive cells, as well as in non-malignant blood diseases, the A3 antigen was localized in nucleoli, and it was visualized as focal fluorescence. In malignant lymphoproliferative diseases with high proliferation indexes, the number of brightly fluorescent foci is observed, with formation of necklace-like structures within the nucleolar structures. The obtained data point to a diagnostic significance of A3 Mab in assessment of cellular proliferative rates in patients with various lymphoproliferative diseases. It was established that, in contrast to Ki-67, the proliferation stage could be determined for each cell, according to the number of fuorescent foci in nucleoli. This specific property of the A3 antigen points to its significance for diagnostics and malignancy staging of lymphoproliferative disorders. |
format |
article |
author |
N. L. Deineko T. I. Bulycheva A. M. Kovrigina A. A. Grigoriyv |
author_facet |
N. L. Deineko T. I. Bulycheva A. M. Kovrigina A. A. Grigoriyv |
author_sort |
N. L. Deineko |
title |
EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES |
title_short |
EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES |
title_full |
EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES |
title_fullStr |
EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES |
title_full_unstemmed |
EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES |
title_sort |
expression of a new a3 antigen in the cells of patients with various lymphoproliferative diseases |
publisher |
SPb RAACI |
publishDate |
2014 |
url |
https://doaj.org/article/ce932ee077a94ad58176c23dd09c4f50 |
work_keys_str_mv |
AT nldeineko expressionofanewa3antigeninthecellsofpatientswithvariouslymphoproliferativediseases AT tibulycheva expressionofanewa3antigeninthecellsofpatientswithvariouslymphoproliferativediseases AT amkovrigina expressionofanewa3antigeninthecellsofpatientswithvariouslymphoproliferativediseases AT aagrigoriyv expressionofanewa3antigeninthecellsofpatientswithvariouslymphoproliferativediseases |
_version_ |
1718422447858909184 |